Abstract: Gap junctions, composed from molecules called connexins, play important roles in cell-to-cell communication and aberrant gap junctional intercellular communication (GJIC) has been reported in many types of cancers. We have established transgenic rats bearing a dominant negative mutant of the connexin 32 gene under control of the albumin promoter. In these rats, GJIC is markedly decreased in the liver, and is associated with increased induction of preneoplastic foci after a single treatment of diethylnitrosamine. In the present study, in order to explore whether organs other than the liver would demonstrate increased susceptibility to a carcinogen, we treated these transgenic rats (having disrupted GJIC of the liver) with diisopropanolnitrosamine (DHPN), a carcinogen targeting multiple organs, such as the liver, lung, kidney and thyroid gland. We found that increased susceptibility for the carcinogenicity was evident only in the liver, but not in the lung, kidney and thyroid gland. This result indicates that disrupted GJIC in the liver influences the liver carcinogenesis, but has no effect on carcinogenesis in other organs. (J Toxicol Pathol 2006; 19: 93-97) 
Introduction
Gap junctional intercellular communication (GJIC) plays important roles in tissue homeostasis 1, 2 , embryonic development 3 and carcinogenesis 4, 5 . Gap junctional channels, which allow exchange or transfer of small molecules less than 1200 Da in mass 1, 2, [6] [7] [8] , consist of face to face hemichannels called connexons, each composed of six connexin protein molecules, encoded by a family of genes with over 20 members 9 . Recently, it was reported that susceptibility to liver carcinogenesis was elevated by a single administration of diethylnitrosamine (DEN) in connexin 32 (Cx32) knock-out mice and in transgenic mice having a dominant-negative mutant of Cx32 [10] [11] [12] [13] [14] . Chemical liver carcinogenesis studies have been more frequently performed on rats than on mice for various reasons. For example, a variety of enzyme-altered liver focal lesions have been studied for their relevance to carcinoma development and glutathione S-transferase placental form (GST-P) positive foci have been utilized as preneoplastic lesions in rats but not in mice [15] [16] [17] [18] . Our medium-term rat liver bioassay for carcinogenicity 18 , based on quantitative evaluation of development of lesions identified by this marker, has detected mutagenic and nonmutagenic hepatocarcinogens in over 313 chemicals so far tested 19 . Recently, we established transgenic rats carrying a dominant negative mutant of Cx32 under control of the albumin promoter 20 . In the liver of this transgenic rat, membrane localization of normal endogenous Cx32 protein is disturbed and gap junction capacity measured by the scrape dye-transfer assay in vivo was markedly decreased compared to the wild-type case. We have found that these GJIC-decreased rats are highly susceptible to induction of preneoplastic foci in the liver by a single injection of DEN 21 .
There is a possibility that decreased cell-to-cell communication in the liver might directly or indirectly influence carcinogenesis in organs/tissues other than the liver. In the present study, to investigate whether organs/ tissues other than the liver might also demonstrate elevated 
Materials and Methods
The production, maintenance, and characterization of the Cx32 disrupted transgenic rats were reported previously 20 . Animals having high-copy numbers of the transgene, named Cx32∆Tg-High, were used in this study. Heterologous transgenic males and females were routinely obtained by mating heterologous transgenic males and wildtype Sprague Dawley females (Japan SLC. Inc., Shizuoka, Japan).
Seventy-two rats aged 6 weeks at the commencement were used for this study. Both sexes of the transgenic and wild-type rat groups were each divided into 2 subgroups (a total of 8 groups), and one of 2 subgroups received DHPN in the drinking water at a dose of 2000 ppm ad libitum for 12 weeks, while the other group was given water without DHPN as controls (Table 1) . Animals which died during the study period were excluded from the data. Surviving animals were sacrificed at experimental week 25. All experiments were performed under protocols approved by the Institutional Animal Care and Use Committee of Nagoya City University Graduate School of Medical Sciences.
Tissue preparation: hematoxylin and eosin staining and GST-P immunostaining were performed routinely. Immediately after sacrifice, the livers were excised, weighed, cut into slices of 2-3 mm thickness, and fixed in ice-cold acetone or buffered formalin, then processed for embedding in paraffin for histological evaluation after GST-P immunostaining or hematoxylin and eosin (H&E) staining, respectively. Sections, 3 µm thick, were cut and incubated with anti-GST-P polyclonal antibody (MBL, Nagoya, Japan) at a dilution of 1:4000. Binding was visualized with a Vectastain Elite ABC kit (Vector Lab, Burlingame, CA) and light hematoxylin counter-staining was conducted. The average numbers and areas of GST-P positive foci >0.2 mm in diameter, and total areas of the liver section were measured with an image analyzer (IPAP; Sumica Technos, Osaka, Japan). All major organs such as the lung, kidney, thyroid and liver were fixed in formalin and processed to H&E stained sections for histopathological assessment of neoplastic lesion induction.
Results
The final body weights of the transgenic and wild-type male rats treated with DHPN were significantly lower than those of their respective untreated counterparts. However, this suppression of body weights was not observed in the females. Regardless of sex or transgene status, lung weights were significantly increased in the DHPN-treated groups. Weights of the livers and kidneys were not significantly affected (Table 1) .
GST-P positive foci development in the liver
DHPN treatment increased the numbers and areas of GST-P positive foci in both males and females regardless of transgene status, but the effect was significantly greater in the male transgenic rats than in wild-type rats. In the females, there was no significant difference (Table 2 and Fig. 1) .
Incidences of tumors with the carcinogen treatment
Lung tumors developed at high incidences in both transgenic and wild-type animals of both sexes given DHPN. Histologically they were composed of hyperplasias, adenomas, adenocarcinomas and squamous cell carcinomas, but no differences were observed between the treated Animals dying in the course of the experiment were excluded from the data. The final body weights of male rats treated with DHPN were significantly smaller than those of non-treated rats. Lung weights were significantly increased in the DHPN-treated groups.
transgenic and wild-type rats (Table 3) . Tumors of the thyroid (follicular carcinomas) and the kidney (adenomas including preneoplastic atypical tubules and transitional cell papilloma and carcinoma) developed less frequently, and more tumors were found in the males than females. However, no significant differences were observed between transgenic and wild-type rats. Lesions of the target organs are summarized in Table 4 . In addition to the liver, lung, thyroid and kidney, a few tumors developed in the bladder, colon, ovary and mammary (data not shown). Similarly, there were no significant differences in these tumor developments between the treated transgenic and wild-type rats. Between the transgenic and wild-type animals, no differences in histological type of developed tumors were noted in all the organs studied. With a few exceptions, tumors were generally not induced in the animals not given DHPN (Table 3) .
Discussion
Cx32 is the major gap junction protein in the liver 22 . Analysis of GST-P positive foci development in the present study confirmed that disrupted gap junctional intercellular c o m m u n i c a t i o n i n t h e r a t l i v e r e n h a n c e s hepatocarcinogenesis of DHPN. However, such difference was not evident in the tumor induction (hepatocellular adenomas), probably because of the short experimental period and/or short duration of DHPN administration. No influence of Cx32 disruption in the liver on tumor induction was noted in any of the target organs other than the liver. The liver is the main organ responsible for the metabolism of exogenous compounds, including carcinogens, and our hypothesis was that signals passed through gap junctions in the liver might affect carcinogenesis indirectly in other organs. However, this was definitely not the case for the lung, kidney and thyroid glands under the present conditions. Thus, our results could be thus in line with the earlier finding that tumor enhancements by radiation were limited to the livers of mice lacking the gap junction protein Cx32
23
. A clear increase of GST-P positive foci was observed in male transgenic rats but not in female transgenic rats. This sex difference can be explained by the fact that in females, despite the copy numbers of the transgene in both male and female transgenic rats being the same, expression of mRNA of the transgene in the liver is very low 20 . In summary, the results of the present study indicate that normal Cx32 expression in the liver plays important roles in rat hepatocarcinogenesis, but does not appear to influence tumor induction in other organs targeted by DHPN. Foci; GST-P positive foci.
